Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |